News

News search

Latest news

Immunotherapy studies open for triple-negative breast cancer
January 22, 2019

Emerging research is finding that immunotherapy may extend survival for some women with triple-negative breast cancer. Providence Cancer Institute, a leader in immunotherapy research, is actively investigating options for this aggressive cancer.

Melanoma study: are two immunotherapies better than one?
December 07, 2018

A newly opened Phase 3 study at Providence Cancer Institute hopes to shed new light on the benefits of two immunotherapies, nivolumab and NKTR-214, for patients with advanced melanoma.